{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T02:50:33Z","timestamp":1773888633739,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Meningiomas are the most common central nervous system tumors in adults, accounting for approximately one-third of the total. Although only 1% to 3% of meningiomas are malignant, these cases exhibit a high degree of aggression and frequent recurrence, resulting in a poor prognosis. There are no accepted treatment standards for salvage re-irradiation. Therefore, detailed case descriptions are essential for treatment guidance.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 56-year-old female with malignant meningioma underwent curative resection and adjuvant radiotherapy (66 Gy in 33 fractions). However, the tumor recurred repeatedly despite curative and salvage therapies. The safety and efficacy of salvage re-irradiation may be limited by potential brain toxicity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Recurrent malignant meningioma.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>The meningioma recurred at the surgical dural bed 4 months after adjuvant radiotherapy, as evidenced by histological analysis following salvage craniotomy. Progressive meningioma was also evident, with invasion to the adjacent skull bone and scalp. Compassionate salvage boron neutron capture therapy (BNCT) was prescribed to eradicate both the recurrent meningioma and bone invasion. The 2 courses of BNCT were administered with mean tumor doses of 41.52 and 50.22 GyE.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>No clinically significant toxicity was observed following irradiation, and imaging showed near-total regression of the brain meningioma and the adjacent invasive skull bone and scalp tumor. Brain symptoms of headache and dizziness also abated after treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>A favorable tumor response with no cranial toxicity was achieved using targeted BNCT therapy. We review the literature on recurrent malignant meningioma and relevant BNCT salvage for further therapeutic guidance.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043743","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:02:40Z","timestamp":1754089360000},"page":"e43743","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Salvage boron neutron capture therapy for recurrent intracranial malignant meningioma: Case report and literature review"],"prefix":"10.1097","volume":"104","author":[{"given":"Li-Ching","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Hsuan","family":"Chow","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Ju","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan-Hung","family":"Wu","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan"},{"name":"School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-Lin","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chin-Hong","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Chi Mei Medical Center, Tainan, Taiwan."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3997-6575","authenticated-orcid":false,"given":"Sheng-Yow","family":"Ho","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Chi Mei Medical Center, Tainan, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1093\/neuonc\/not151","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2006-2010.","volume":"15","author":"Ostrom","year":"2013","journal-title":"Neuro-Oncology"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fpubh.2016.00151","article-title":"Comparative brain and central nervous system tumor incidence and survival between the United States and Taiwan based on population-based registry.","volume":"4","author":"Chien","year":"2016","journal-title":"Front Public Health"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s11060-024-04720-4","article-title":"The role of adjuvant radiotherapy for intracranial malignant meningiomas: analysis of a nationwide database.","volume":"169","author":"Ho","year":"2024","journal-title":"J Neurooncol"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3171\/2016.11.JNS161170","article-title":"Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539.","volume":"129","author":"Rogers","year":"2017","journal-title":"J Neurosurg"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3390\/cancers16122267","article-title":"Topographic patterns of intracranial meningioma recurrences \u2013 systematic review with clinical implication.","volume":"16","author":"Corvino","year":"2024","journal-title":"Cancers"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"798","DOI":"10.3171\/2022.12.JNS222010","article-title":"Impact of salvage surgery with or without reirradiation for skull base meningiomas recurring after prior radiotherapy.","volume":"139","author":"Rubino","year":"2023","journal-title":"J Neurosurg"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"11","DOI":"10.14338\/IJPT-18-00045.1","article-title":"Clinical outcomes of recurrent intracranial meningiomas treated with proton beam reirradiation.","volume":"5","author":"Imber","year":"2019","journal-title":"Int J Particle Ther"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"4978","DOI":"10.3390\/ijms24054978","article-title":"Advances in boron neutron capture therapy (BNCT) for recurrent intracranial meningioma.","volume":"24","author":"Lan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3171\/2013.5.JNS122204","article-title":"Boron neutron capture therapy for recurrent high-grade meningiomas.","volume":"119","author":"Kawabata","year":"2013","journal-title":"J Neurosurg"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3171\/jns.2006.105.6.898","article-title":"Boron neutron capture therapy for recurrent malignant meningioma: case report.","volume":"105","author":"Tamura","year":"2006","journal-title":"J Neurosurg"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1093\/neuonc\/noab108","article-title":"Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up.","volume":"24","author":"Takai","year":"2022","journal-title":"Neuro-Oncology"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3390\/life12040566","article-title":"Compassionate treatment of brainstem tumors with boron neutron capture therapy: a case series.","volume":"12","author":"Chen","year":"2022","journal-title":"Life"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"100633","DOI":"10.1016\/j.ijpt.2024.100633","article-title":"The level of circulating M-MDSCs as an indicator for the therapeutic outcome of BNCT in end-stage malignant brain tumor patients.","volume":"14","author":"Chang","year":"2024","journal-title":"Int J Particle Ther"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"E461","DOI":"10.1093\/neuros\/nyy610","article-title":"Malignant meningioma: an international multicentre retrospective study.","volume":"85","author":"Champeaux","year":"2019","journal-title":"Neurosurgery"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-017-2436-6","article-title":"Atypical and anaplastic meningioma: outcomes in a population based study.","volume":"133","author":"Garzon-Muvdi","year":"2017","journal-title":"J Neurooncol"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.wneu.2017.01.070","article-title":"Metastatic atypical and anaplastic meningioma: a case series and review of the literature.","volume":"101","author":"Kessler","year":"2017","journal-title":"World Neurosurg"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/neup.12177","article-title":"Two cases of atypical meningioma with pulmonary metastases: a comparative cytogenetic analysis of chromosomes 1p and 22 and a review of the literature.","volume":"35","author":"Frydrychowicz","year":"2014","journal-title":"Neuropathology"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"152390","DOI":"10.1016\/j.prp.2019.03.018","article-title":"Low grade intracranial meningioma presenting with pulmonary metastasis: case report and literature review.","volume":"215","author":"Sathirareuangchai","year":"2019","journal-title":"Pathol Res Pract"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/s41467-022-29052-7","article-title":"Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomas.","volume":"13","author":"Brastianos","year":"2022","journal-title":"Nat Commun"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043743","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:01:16Z","timestamp":1758232876000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":19,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043743","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"value":"2025-04-29","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}